Dexcom’s continuous glucose monitor (CGM) technology is transforming how patients measure their sugar levels by simplifying their diabetes management, CEO Kevin Sayer explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Sayer sits down with BI analyst Matt Henriksson for an in-depth interview to talk about the company, its new G7 launch, expanded reimbursement coverage and marketing with recording artist, songwriter and Type 1 diabetes patient Nick Jonas.

See omnystudio.com/listener for privacy information.